RXMD- Excited to see what 2018 Brings. RXMD had a great year . Hopefully CEO now understands the importance of under Promising and over delivering. A "GREAT YEAR" although RXMD projection wasn't hit.
An OTC with close to 20 MILLION IN Gross REVENUE!
The Problem: FAILURE by a CEO in PENNYLAND, is not only an Acceptable Practice, it REWARDS a CEO... It's much EASIER for CEO to make money selling Company shares, than Build a Company.